Amylon Therapeutics

Amylon Therapeutics is a biotechnology company developing therapies for rare genetic disorders of the central nervous system. Its drug development platform is based on RNA Modulation Technology using antisense oligonucleotides (ASOs) to alter the splicing of pre-mRNA to counteract the effects of disease-causing mutations.